Ann Hynes
Stock Analyst at Mizuho
(4.09)
# 463
Out of 5,180 analysts
290
Total ratings
59.45%
Success rate
8.73%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $50 → $52 | $41.54 | +25.18% | 5 | Mar 18, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $235 → $265 | $188.00 | +40.96% | 17 | Mar 12, 2026 | |
| MOH Molina Healthcare | Maintains: Outperform | $220 → $180 | $131.47 | +36.91% | 10 | Mar 12, 2026 | |
| ELV Elevance Health | Maintains: Outperform | $413 → $350 | $284.79 | +22.90% | 7 | Mar 11, 2026 | |
| CNC Centene | Maintains: Neutral | $47 → $41 | $31.80 | +28.93% | 10 | Mar 11, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $11.60 | +46.55% | 5 | Mar 5, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $467.83 | +25.05% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $159.72 | +9.57% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $197.16 | +19.19% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $261.79 | +33.69% | 22 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $13 | $8.87 | +46.56% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $12 | $8.26 | +45.28% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $22.83 | -25.54% | 13 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $70.14 | +35.44% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $460.30 | +42.30% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $263.61 | +21.39% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $166.00 | +107.83% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $166.16 | +35.41% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $105.10 | +114.08% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $20.80 | -27.88% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $206.31 | -41.84% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $21.05 | +33.02% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $97.52 | -2.58% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $258.08 | +49.18% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $182.10 | +9.83% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.27 | +21,002.36% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $860.19 | -41.29% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.76 | +7,434.70% | 1 | Sep 21, 2017 |
BrightSpring Health Services
Mar 18, 2026
Maintains: Outperform
Price Target: $50 → $52
Current: $41.54
Upside: +25.18%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235 → $265
Current: $188.00
Upside: +40.96%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220 → $180
Current: $131.47
Upside: +36.91%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413 → $350
Current: $284.79
Upside: +22.90%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47 → $41
Current: $31.80
Upside: +28.93%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $11.60
Upside: +46.55%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $467.83
Upside: +25.05%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $159.72
Upside: +9.57%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $197.16
Upside: +19.19%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $261.79
Upside: +33.69%
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $8.87
Upside: +46.56%
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $8.26
Upside: +45.28%
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $22.83
Upside: -25.54%
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $70.14
Upside: +35.44%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $460.30
Upside: +42.30%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $263.61
Upside: +21.39%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $166.00
Upside: +107.83%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $166.16
Upside: +35.41%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $105.10
Upside: +114.08%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $20.80
Upside: -27.88%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $206.31
Upside: -41.84%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $21.05
Upside: +33.02%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $97.52
Upside: -2.58%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $258.08
Upside: +49.18%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $182.10
Upside: +9.83%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.27
Upside: +21,002.36%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $860.19
Upside: -41.29%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.76
Upside: +7,434.70%